SCHEMBL23314664

SCHEMBL23314664

C[C@@H]1NC(=O)C(N(C)C(=O)CNC=O)c2ccc(OCCN)c(c2)-c2cc(ccc2OCCN)CC(C(=O)O)NC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23314594 0.92 — —
SCHEMBL25982267 0.92 — —
SCHEMBL26937228 0.90 — —
SCHEMBL23314722 0.90 — —
SCHEMBL25980053 0.90 — —
SCHEMBL25979685 0.89 — —
SCHEMBL23314713 0.87 — —
SCHEMBL25979828 0.86 — —
SCHEMBL18681222 0.85 PDE4A (0.33) —
SCHEMBL23314807 0.85 PDE4A (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3145944-B1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX PHARMACEUTICALS INC (US) 2021-05-05 — — EP disclosed
Send feedback